Zoetis Inc (NYSE:ZTS)

208.65
Delayed Data
As of 4:00pm ET
 +0.03 / +0.01%
Today’s Change
141.41
Today|||52-Week Range
210.10
+26.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$95.8B

Company Description

Zoetis, Inc. discovers, develops, and manufactures a portfolio of animal health medicines and vaccines. The firm operates through the following segments: United States &International. Its products are complemented by diagnostic products, genetic tests, bio devices, and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal. The company provides its services though five categories namely, anti-invectives, vaccines, parasitic ides, medicated feed additives, and other pharmaceuticals. Zoetis was founded in 1952 and is headquartered in Parsippany, NJ.

Contact Information

Zoetis, Inc.
10 Sylvan Way
Parsippany New Jersey 07054
P:(973) 822-7000
Investor Relations:

Employees

Shareholders

Other institutional47.14%
Mutual fund holders45.67%
Individual stakeholders27.12%

Top Executives

Kristin C. PeckChief Executive Officer & Director
Roxanne LaganoChief Human Resources Officer
Wetteny JosephCFO, EVP & Head-Business Development
Catherine Ann KnuppExecutive VP, President-Research & Development
Wafaa MamilliChief Information & Digital Officer